As the healthcare landscape continues to evolve, the India clinical trials market is poised for substantial growth. Recent projections foresee the market reaching an estimated size of USD 6 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.24%. This upward trajectory is largely attributed to regulatory reforms that aim to enhance the approval process and streamline clinical...